TRex Bio TRXB
NASDAQ TRXB
$14.25 +1.12 (+8.53%)
At close: Nov 11, 2026 · 4:00 PM EST

TRex Bio (TRXB) Operating Leases (2024 - 2026)

Analysis

TRex Bio (TRXB) Operating Leases (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 TRex Bio 53.20 Mn -37.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 197,000.00
Dec 31, 2025 717,000.00
Dec 31, 2024 696,000.00
API Access

TRex Bio Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=TRXB&period=max&api_key=YOUR_API_KEY